• Cefotaxime in Antimicrobial Resistance Models: Protocols & I

  2026-07-10

  Cefotaxime, a third-generation cephalosporin antibiotic, is a cornerstone for modeling Gram-positive and Gram-negative bacterial infections and dissecting antimicrobial resistance mechanisms. This article delivers actionable protocols, advanced applications, and troubleshooting strategies for leveraging Cefotaxime in resistance research, backed by the latest molecular epidemiology findings from Guangdong hospitals.

• Diuron (3-(3,4-dichlorophenyl)-1,1-dimethylurea) in Toxicolo

  2026-07-09

  Diuron is not just a benchmark photosynthesis inhibitor but a pivotal tool in dissecting nephrotoxicity mechanisms, thanks to recent network toxicology advances. This article delivers actionable protocols, troubleshooting insights, and cross-domain strategies for maximizing the impact of APExBIO's high-purity Diuron in plant and environmental research.

• Transmission Dynamics of Carbapenemase Genes in CREC in Guan

  2026-07-09

  This study systematically characterizes the genetic and epidemiological landscape of carbapenemase-encoding genes (CEGs) in carbapenem-resistant Enterobacter cloacae (CREC) from eight hospitals in Guangdong during the pandemic period. It reveals a high prevalence and plasmid mobility of blaNDM-1, mapping multidrug resistance patterns and informing both diagnostics and antimicrobial research.

• Fenofibrate as a PPARα Agonist: Workflows for Liver and Canc

  2026-07-08

  Fenofibrate, a potent PPARα agonist from APExBIO, empowers cutting-edge research in lipid metabolism and cancer biology via robust activation of the PPARα-YAP signaling axis. This article details workflow enhancements, troubleshooting, and practical insights—anchored in new evidence that Fenofibrate's hepatic effects are age-independent.

• DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe: Te

  2026-07-08

  DiI (DiIC18(3)) Plasma Membrane Orange Fluorescent Probe addresses the need for high-contrast, selective plasma membrane labeling in live and fixed cell studies, including neuronal tracing and cell migration assays. It should not be used for aqueous staining or exclusive intracellular organelle targeting, as its solubility and specificity are restricted to lipid environments.

• RWJ 67657: Precision p38α/β Inhibition for Inflammatory Mode

  2026-07-07

  RWJ 67657 (JNJ-3026582) sets a new standard for selective p38 MAP kinase inhibition in inflammatory disease research. Its dual-action mechanism—potently blocking p38α/β and accelerating dephosphorylation—enables robust, reproducible cytokine modulation in cell and animal models.

• Radiotherapy, PD-1, and TIGIT Blockade: CD8+ T Cell-Driven A

  2026-07-07

  This study demonstrates that combining radiotherapy with PD-1 and TIGIT blockade robustly enhances antitumor abscopal effects and immune memory through CD8+ T cell activation and M1 macrophage polarization. The findings offer important mechanistic insights for improving immunotherapy efficacy and overcoming immune resistance in cancer.

• 3-Methyladenine in Autophagy Research: Protocols, Tips & Adv

  2026-07-06

  Unlock the full experimental potential of 3-Methyladenine (3-MA) with optimized protocols for autophagy inhibition and advanced workflow guidance. Learn how the latest reference study bridges neuroprotection and autophagy, and get actionable troubleshooting solutions for reproducible results.

• Evaluating Biomimetic Chromatography for Pulmonary Drug Perm

  2026-07-06

  This study rigorously compares immobilised artificial membrane liquid chromatography (IAM LC) and liposome electrokinetic capillary chromatography (LEKC) for modeling drug partitioning and predicting pulmonary permeability. The findings demonstrate that LEKC more accurately simulates lung membrane interactions for drug delivery, while IAM LC offers broader compound applicability and higher throughput—providing nuanced guidance for permeability modeling in antiretroviral and related drug research.

• AG-126 (Tyrphostin AG-126): Precision ERK Modulation in Neur

  2026-07-05

  AG-126 (Tyrphostin AG-126) offers researchers a potent, selective tool for dissecting ERK1/2 signaling in complex neurobiological models. Its robust performance in in vitro and in vivo protocols enables targeted investigation of circuit dynamics underlying repetitive behaviors and neuroinflammation, setting it apart from less selective MAPK/ERK pathway inhibitors.

• 5-Methyl-CTP: Enhancing mRNA Synthesis for Advanced Vaccines

  2026-07-04

  5-Methyl-CTP empowers researchers to synthesize highly stable, translationally efficient mRNA, accelerating vaccine innovation and gene expression studies. This article translates cutting-edge findings into actionable workflows while troubleshooting common pitfalls in mRNA synthesis with modified nucleotides.

• EdU Cell Proliferation Kit (TMB): Precision S-Phase Detectio

  2026-07-03

  Explore how the EdU Cell Proliferation Kit (TMB) advances 5-ethynyl-2'-deoxyuridine proliferation assays for high-sensitivity S-phase detection in complex cell systems. This article uniquely connects molecular assay design with translational insights from ARL4C-driven rheumatoid arthritis research.

• U 46619: Precision Tool for Platelet Aggregation and Vascula

  2026-07-03

  U 46619 (11,9 epoxymethano-prostaglandin H2) offers unmatched control in dissecting TP receptor-mediated platelet and vascular responses. This article delivers stepwise protocols, actionable troubleshooting, and insight into leveraging U 46619 for advanced cardiovascular and renal research models.

• Pedalitin Modulates Lipid and Inflammatory Pathways in NAFLD

  2026-07-02

  This study demonstrates that Pedalitin, a flavonoid from black sesame, regulates lipid metabolism and attenuates inflammatory signaling in a non-alcoholic fatty liver disease (NAFLD) cell model. Using integrated network pharmacology, molecular docking, and RT-qPCR, the authors reveal that Pedalitin targets key metabolic and immune pathways, supporting the prospect of plant-derived compounds in NAFLD intervention.

• Mianserin HCl: Mechanistic Insight for Translational Excelle

  2026-07-02

  This thought-leadership article unpacks the mechanistic underpinnings and strategic research applications of Mianserin Hydrochloride (Mianserin HCl), a unique 5-HT2 receptor antagonist. Bridging foundational antidepressant research, competitive clinical benchmarking, and translational workflow design, we illuminate how APExBIO’s Mianserin HCl empowers neuroscience and psychiatric disorder research with evidence-based rigor, versatility, and a roadmap for future discovery.

455 records 12/31 page Previous Next First page 上5页 1112131415 下5页 Last page